Phase II, Randomized, Placebo Controlled Trial of the Safety and Tolerability of Mycophenolate in Children With Juvenile Neuronal Ceroid Lipofuscinosis.
Phase of Trial: Phase II
Latest Information Update: 09 Dec 2015
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Neuronal ceroid lipofuscinosis
- Focus Adverse reactions
- Acronyms JUMP
- Sponsors University of Rochester
- 04 Dec 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 14 Aug 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record
- 18 Mar 2013 Planned end date changed from 1 Aug 2014 to 1 Aug 2015 as reported by ClinicalTrials.gov.